Beam Therapeutics Inc. (NASDAQ: BEAM ) is a precision-genetics firm that pioneers base editing. Essentially, they’re working on one-time ex vivo and in vivo treatments for durable, potentially functional cures for hematology and liver genetic diseases. That’s why I believeMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a g ...